69.2Mt @ 2.5% palladium sounds a bit optimistic...maybe this old article from April was written in double-Deutsch?
Pretty sure you are permitted to do a DCF if it's in double-deutsch even if you don't start with a JORC 2012 resource...lol.
Think that Hayden Bairstow from Macquarie and their investors will be very disappointed with the upcoming maiden resource estimate for Julimar.
High-grade lode structures at Julimar appear angled @ ~45 degrees to the current drill orientation thus increasing the actual true thickness of reported primary intersections by a factor of 1.3-1.4 (same problem exists for flat, saprolite results).
Furthermore, the number of lodes reported by CHN (11) appears grossly exaggerated given offset of primary sulfide concentrations either side of north-south-trending dolerite dykes.
There are only five primary lodes separated by 10-15% barren (post-mineralisation) dolerite based on my interpretation of drilling to date.
This downgrades current analyst volume guestimates of mineralisation by more than 50%.
Lastly, continuity into the area of state forest (Hartog), based upon Airborne EM, is not supported by surface geochemistry.
P
- Forums
- ASX - By Stock
- CHN
- Fair Price for CHN with current resource ?
Fair Price for CHN with current resource ?, page-255
Featured News
Add CHN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.49 |
Change
-0.035(2.30%) |
Mkt cap ! $577.7M |
Open | High | Low | Value | Volume |
$1.48 | $1.56 | $1.46 | $5.624M | 3.772M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 65961 | $1.48 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.50 | 20387 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 65961 | 1.480 |
2 | 29750 | 1.475 |
1 | 14750 | 1.470 |
1 | 14750 | 1.465 |
3 | 17750 | 1.460 |
Price($) | Vol. | No. |
---|---|---|
1.495 | 20387 | 1 |
1.500 | 2553 | 1 |
1.505 | 14750 | 1 |
1.510 | 14750 | 1 |
1.515 | 69411 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
CHN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online